Skip to Main Content

Implementation Science (Eastern Europe/Central Asia)

Credit: Adobe Stock
Eastern Europe

Yale’s implementation science work aims to scale up HIV prevention and treatment in eastern Europe and central Asia. This region is the largest area of the world where HIV incidence and mortality continue to increase despite global reductions.

This increase is largely driven by suboptimal levels of HIV prevention and treatment. We are using innovative implementation science methods and analyses to increase HIV prevention and treatment in:

  • Addiction treatment settings in Ukraine (R01 DA033679) and in three countries and central Asia (R01 DA054851)
  • Psychiatric centers (R01 DA045384) – Cluster RCT
  • Criminal justice settings – five countries (R01 DA029910; K01 DA047194)
  • Studies of HIV and aging (R21 AG072961)
  • Mathematical modeling studies of HIV prevention and treatment in the region, including in communities and prisons (R21 DA047902)

Research Team

  • Director

    Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health; Director, Yale Center for Clinical and Community Research, Department of Medicine; Director, HIV in Prisons Program, Infectious Diseases; Director, Community Health Care Van, Intersection of Infectious Diseases and Substance Use Disorders/Addiction Medicine; Academic Icon Professor of Medicine, University of Malaya-Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine , University of Malaya

  • Kostyantyn Dumchev
  • Sergii Dvoriak

    Professor, Doctor of Medical Sciences; Senior Researcher, European Institute of Public Health Policy; Head of the Board, Founder and Senior Scientist, Ukrainian Institute on Public Health Policy

  • Associate Professor of Medicine (Infectious Diseases, AIDS) and Epidemiology in the Department of Chronic Disease Epidemiology; Program Director, Infectious Diseases Fellowship, Infectious Diseases

  • Maxim Polonsky